Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Subsequently, the sections were incubated with secondary antibody (goat anti-rabbit), rinsed with phosphate buffer saline (PBS), stained with DAB, and hematoxylin and eosin (H&E) staining, dehydrated, transparentized, and mounted before microscopic analysis
Our bodies dont create it, meaning we have to receive it from diet or supplementation
For people sensitive to oxalates, the body may struggle to process them, leading to symptoms related to the accumulation of oxalate crystals in tissues, including joints and kidneys
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
US$ 20.62
US$ 21.43
US$ 26.03
